Fijación de metas inflacionarias en una economía dolarizada: la experiencia de Perú

(Disponible en idioma inglés únicamente) En este trabajo se trata la experiencia única del Banco Central de Reserva de Perú con la fijación de metas inflacionarias, en una economía caracterizada por un elevado grado de dolarización financiera. Se esboza la manera en que Perú ha tomado en cuenta la dolarización de su sistema financiero en el diseño de su política monetaria, luego se trata la puesta en práctica de la política monetaria y la estrategia del Banco Central para controlar los riesgos de la dolarización del sistema financiero. El trabajo concluye con un análisis y las enseñanzas que arroja el caso peruano.

De metas monetarias a metas de inflación en una economía con dolarización parcial: El caso peruano

Clasificación JEL:

Targeting Inflation in a Dollarized Economy: The Peruvian Experience

This discusses the unique experience of Peru`s Central Bank with inflation targeting in an economy characterized by a high degree of financial dollarization. The paper outlines how Peru has taken financial dollarization into consideration in the design of monetary policy, then deals with monetary policy implementation and the Central Bank`s strategy for controlling financial dollarization risks. The paper concludes with analysis and lessons drawn from the Peruvian case

Targeting Inflation in a Dollarized Economy: The Peruvian Experience

This discusses the unique experience of Peru's Central Bank with inflation targeting in an economy characterized by a high degree of financial dollarization. The paper outlines how Peru has taken financial dollarization into consideration in the design of monetary policy, then deals with monetary policy implementation and the Central Bank's strategy for controlling financial dollarization risks. The paper concludes with analysis and lessons drawn from the Peruvian case

Intervenciones cambiarias

¿Son las intervenciones cambiarias que efectúa el Banco Central, consistentes con su esquema de metas explícitas de inflación usado desde 2002? En este artículo se busca responder esta pregunta.

Insights into Pathogenesis, Nutritional and Drug Approach in Sarcopenia: A Systematic Review

Sarcopenia is a multifactorial condition related to the loss of muscle mass and strength due to aging, eating habits, physical inactivity, or even caused by another disease. Affected individuals have a higher risk of falls and may be associated with heart disease, respiratory diseases, cognitive impairment, and consequently an increased risk of hospitalization, in addition to causing an economic impact due to the high cost of care during the stay in hospitals. The standardization of appropriate treatment for patients with sarcopenia that could help reduce pathology-related morbidity is necessary. For these reasons, this study aimed to perform a systematic review of the role of nutrition and drugs that could ameliorate the health and quality of life of sarcopenic patients and PRISMA guidelines were followed. Lifestyle interventions have shown a profound impact on sarcopenia treatment but using supplements and different drugs can also impact skeletal muscle maintenance. Creatine, leucine, branched-chain amino acids, omega 3, and vitamin D can show benefits. Although with controversial results, medications such as Metformin, GLP-1, losartan, statin, growth hormone, and dipeptidyl peptidase 4 inhibitors have also been considered and can alter the sarcopenic’s metabolic parameters, protect against cardiovascular diseases and outcomes, while protecting muscles